Clinical Trials Directory

Trials / Completed

CompletedNCT05387395

COVID-19 on Disease Activity in Radiologically Isolated Syndrome Cohort

Impact of COVID 19 Vaccination or Infection on Disease Activity in Radiologically Isolated Syndrome Cohort: the VaxiRIS Study

Status
Completed
Phase
Study type
Observational
Enrollment
217 (actual)
Sponsor
Centre Hospitalier Universitaire de Nice · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The Radiologically Isolated Syndrome (RIS) is defined as incidental Magnetic Resonance Imaging (MRI) abnormalities fulfil the criteria for dissemination in space, suggestive of multiple sclerosis. Nowadays, mandatory vaccination in patients with multiple sclerosis (MS) is widely recommended. Regarding COVID19, the absence of specific warnings led to the proposal of vaccination in patients with inflammatory diseases of the central nervous system. We aimed to evaluate if COVID19 vaccination or infection increased the risk of clinical conversion to multiple sclerosis or evidence of disease activity (EDA) in a cohort of RIS subjects.

Conditions

Interventions

TypeNameDescription
OTHERNO interventionno intervention

Timeline

Start date
2022-05-31
Primary completion
2022-07-01
Completion
2022-07-01
First posted
2022-05-24
Last updated
2022-08-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05387395. Inclusion in this directory is not an endorsement.

COVID-19 on Disease Activity in Radiologically Isolated Syndrome Cohort (NCT05387395) · Clinical Trials Directory